Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy
- 30 April 2011
- journal article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 50 (4) , 287-291
- https://doi.org/10.1016/j.jcv.2011.01.004
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Recombinant Phenotyping of Cytomegalovirus Sequence Variants Detected After 200 or 100 Days of Valganciclovir ProphylaxisTransplantation, 2010
- Differentiation between Polymorphisms and Resistance-Associated Mutations in Human Cytomegalovirus DNA PolymeraseAntimicrobial Agents and Chemotherapy, 2010
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- Recombinant Phenotyping of Cytomegalovirus UL97 Kinase Sequence Variants for Ganciclovir ResistanceAntimicrobial Agents and Chemotherapy, 2010
- Diverse Cytomegalovirus UL27 Mutations Adapt to Loss of Viral UL97 Kinase Activity under MaribavirAntimicrobial Agents and Chemotherapy, 2009
- Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locusJournal of Clinical Virology, 2008
- Growth and Drug Resistance Phenotypes Resulting from Cytomegalovirus DNA Polymerase Region III Mutations Observed in Clinical SpecimensAntimicrobial Agents and Chemotherapy, 2007
- Cytomegalovirus UL97 Kinase Mutations That Confer Maribavir ResistanceThe Journal of Infectious Diseases, 2007
- Multidrug Resistance Conferred by Novel DNA Polymerase Mutations in Human Cytomegalovirus IsolatesAntimicrobial Agents and Chemotherapy, 2007
- Analysis and Characterization of Antiviral Drug–Resistant Cytomegalovirus Isolates from Solid Organ Transplant RecipientsThe Journal of Infectious Diseases, 2002